Impact of lipid and ACE inhibitor therapy on cardiovascular disease and metabolic abnormalities in the diabetic and hypertensive patient
- 1 January 1997
- journal article
- research article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 11 (1) , 9-16
- https://doi.org/10.1038/sj.jhh.1000394
Abstract
Journal of Human Hypertension is exclusively concerned with all clinical aspects of human hypertension. The journal publishes fully refereed original research papers from around the world.Keywords
This publication has 29 references indexed in Scilit:
- Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling projectPublished by Elsevier ,2004
- Lipoprotein (a) Levels in Diabetes Mellitus: Relationship to Metabolic ControlAnnals of Internal Medicine, 1992
- The Effect of Near-Normoglycemic Control on Plasma Factor VIII/von Willebrand Factor and Fibrin Degradation Products in Insulin-Dependent Diabetic Patients*Journal of Clinical Endocrinology & Metabolism, 1989
- Mesangial cells express PDGF mRNAs and proliferate in response to PDGFAmerican Journal of Physiology-Renal Physiology, 1988
- Increased expression of basement membrane components in human endothelial cells cultured in high glucose.Journal of Clinical Investigation, 1988
- High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984